Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
New Jersey Law Firm Assists Victims During Fungal Meningitis Outbreak From Tainted Epidural Steroid Injections
New Jersey personal injury lawyer Scott Grossman is currently investigating the current Fungal Meningitis outbreak in New Jersey and in several other states and is making himself available to victims for consultation. The United States Centers for Disease Control and Prevention (CDC) announced that... - October 15, 2012 - The Grossman Law Firm, LLC
New Omega-3 Structure Function Claim for DHA-Rich Algae Oil
Source-Omega today forwarded new structure function claims for dietary omega-3 intake from a single algae oil. Both omega-3 docosahexaenoic acid (DHA) and omega-3 eicosapentaenoic acid (EPA) are present in their oil. As a supplier, the company has defined DHA-rich algae oil uses in very low density... - October 11, 2012 - Source-Omega
Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Muscle Growth in Rosa’s Impact Webinar Series
Dr. Singh, will present “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” Webinar October 17, 2012. - October 10, 2012 - Rosa & Co LLC
Dr Emil Haldey to Discuss Compounding in the Modern Dermatology Practice at the Mount Sinai Medical Center, October 18, 2012
Dr Emil J. Haldey will speak about history, rationale, and benefits of compounding for modern dermatology practice at the Mount Sinai Medical Center. Dr Haldey continuously researches the field and will discuss the most relevant topics. - October 10, 2012 - Emilior Pharmaceutical Compounding
Results of Type C Guidance Meeting with Food & Drug Administration (FDA) of ZYDIS® ODT Fluoxetine in the Treatment of Repetitive Behaviors in Autism
Autism Therapeutics LLC ("Autism Therapeutics") announced today that the Type C Guidance Meeting with FDA to discuss the ZYDIS® ODT Fluoxetine / Autism program has taken place. The FDA and Autism Therapeutics discussed the completion of the Phase III development of the program... - October 09, 2012 - Autism Therapeutics LLC
90 People Sickened with Meningitis from Tainted Epidural Pain Shots
The victims of contaminated epidural shots who have contracted meningitis have legal rights. Bagolie Friedman Injury Lawyers is ready to answer any questions the public may have related to these potential claims. As always the consultations are free and confidential. - October 09, 2012 - Bagolie Friedman Injury Lawyers
"Sandoz Will be the Leading Biosimilar Drug Company in 2012, with Revenue of $308 Million" Predicts New Visiongain Report
A new report by Visiongain predicts that Sandoz will retain its position as the global leader in the biosimilar drugs market in 2012. In that year, its three follow-on biologics will achieve $308m in revenue. Combined revenue for the top three companies in that market will grow with a CAGR of close to 25% between 2011 and 2016. Those findings, and others, appear in Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022, published in 1st October 2012. - October 07, 2012 - visiongain
Diabecline Antibiotic Receives Drug Store News Award
Diabecline® first aid antibiotic, offered by pharmaCline®, has been named the winner of the Drug Store News Best New Product award. This recognition was by vote of key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, N.C. Drug Store News... - October 05, 2012 - pharmaCline
IonSense® Introduces the OpenSpot Quick Strips™ for the DART OS Transmission Module™, Providing Rapid Analysis in Food Safety and Product Quality
New Product to be exhibited at the AOAC International Annual Meeting and Exposition in Las Vegas, NV October 1 through October 4, 2012 - October 01, 2012 - IonSense, Inc.
IonSense, Inc. Issued Two Patents on Direct Analysis in Real Time Mass Spectrometry. Introduces New Product at International Mass Spectrometry Conference, Kyoto, Japan.
New DART-OS Source Demonstrated Live to Meeting Attendees, Highlighting Applications in Food Safety and Forensics. - September 27, 2012 - IonSense, Inc.
Pharma Anti- Counterfeiting 2012 by Virtue Insight Ltd on 18th October 2012, UK
Virtue Insight Ltd is pleased to announce “Pharma Anti- Counterfeiting 2012 – Competences to Combat Counterfeits in EU & USA” on 18th October 2012 at Marriott Marble Arch Hotel, London, UK. Visit: http://www.virtueinsight.com/pharma/Pharma-Anti-Counterfeiting-2012/ This... - September 21, 2012 - Virtue Insight
Source-Omega Claims JAMA Meta-Study Unethical; Calls for Ban of the Word Omega-3 on Drug Labels
Source-Omega says the Food and Drug Administration may need to ban the use of the word omega-3 on all drug labels and descriptions. That is, if omega-3 is only a food word. This is at issue because the company says the September 12th JAMA study also misleads those benefiting from current... - September 20, 2012 - Source-Omega
Ameridose Sponsors Health Connect Partners' 2012 Fall Hospital Pharmacy Conference
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce its sponsorship of Health Connect Partners’ 2012 Fall Hospital Pharmacy Conference, September 24-26 at the Hyatt Regency in Dallas, Texas. - September 19, 2012 - Ameridose, LLC
The Boulder Group Publishes Net Lease Drug Store Market Research Report
Net lease drug store cap rates compressed across the board - September 15, 2012 - The Boulder Group
pharmaCline Announces Poster Presentation at the Symposium for the Advancement of Wound Care Fall 2012
The poster entitled, “Multi-case Human Field Studies of Diabetic Foot Injuries Treated with Tetracycline delivered by SSPT™: A Novel Delivery System Yields Effective Results” is authored by Dr. Christopher Ayo Otiko, DPM, and features three unique clinical case studies. - September 13, 2012 - pharmaCline
"Pharma Lyophilisation Market Will Reach $2.48 Billion in 2012" Predicts Visiongain Report
A new report by visiongain predicts that the 2012 world market for lyophilisation (freeze drying) products and services for pharma will reach $2.48 billion. That revenue forecast and others appear in Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022, published in September 2012. Visiongain is a business information provider based in London, UK. - September 13, 2012 - visiongain
"Painkillers Market Will Reach $61.6 Billion in 2012" Visiongain Report Predicts
A new report by visiongain predicts that the world market for drugs to relieve pain will reach $61.6 billion for 2012. That revenue forecast appears in World Pain Relieving Drug Market 2012-2022, published in September 2012. Visiongain is a business information provider based in London, UK. - September 13, 2012 - visiongain
New Visiongain Report Shows Commercial Prospects for the 20 Leading Biopharmaceutical Companies
A new report by visiongain assesses prospects for the leading 20 biopharma companies worldwide. Top pharmaceutical companies have consolidated their hold on the market by buying up most of the leading biotech products and platforms, according to Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022, published in September 2012. - September 13, 2012 - visiongain
Sentrx Unveils New, User-Friendly Website
Sentrx introduces a new and improved website located at www.Sentrx.com. - September 12, 2012 - Sentrx
"Pharmaceutical Contract Manufacturing Market Will Reach $47.6 Billion in 2012" Predicts Visiongain Report
A new report by visiongain predicts that the world market for pharmaceutical contract manufacturing will be worth $47.6 billion in 2012. Between 2011 and 2016, the overall market will grow with a compound annual growth rate (CAGR) of over 6%. Demand for outsourcing will increase worldwide, driving revenue growth. Those findings and others appear in Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022, published in August 2012. - September 11, 2012 - visiongain
Breakout Discussion Groups Announced at CHI's Immunogenicity Summit 2012 in Bethesda, MD, Oct. 10-12
Delegates now have the option to choose from 10 moderated breakout discussion groups at this industry leading event facilitated by FDA and industry and academic experts. - September 11, 2012 - Cambridge Healthtech Institute
Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa’s Impact Webinar Series
Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012. - September 08, 2012 - Rosa & Co LLC
Speed Script and RxMedic Combine Pharmacy Management System with Automated Dispensing
Speed Script and RxMedic team up to offer a pharmacy management system that integrates the latest pharmacy robot with software that verifies filled prescriptions and completes other tasks. This equipment helps improve workflow management at a small or large pharmacy. - September 08, 2012 - RxMedic
MedPro Rx, Inc. Ranked Second Among Triangle Top Small Businesses by Business Leader Magazine
Local Specialty Infusion Pharmacy Takes Second Place in Small Business Competition - August 31, 2012 - MedPro Rx, Inc.
GlaxoSmithKline and Rosa Present Psoriasis Collaboration Results at 17th International IRA Conference
PhysioPD™ modeling collaboration in psoriasis to be presented September 9-13, 2012. - August 14, 2012 - Rosa & Co LLC
VIRUN® Closes $2.1 Million Series-A Funding to Bolster Innovation and World-Wide Expansion
After almost 10 years of self-funding growth and business expansion, VIRUN is ready to further-illuminate its presence and capitalize on its patented technology portfolio and product development. - August 02, 2012 - VIRUN
Rosa to Present Mechanistic Systems Pharmacology Workshop at 2012 ICSB Conference
Workshop focused on Rosa’s Model Qualification Method to be held August 19th, Toronto, Canada. - August 02, 2012 - Rosa & Co LLC
Drug Risk/Benefit Analysis; Sentrx Comments New E.U. Regulations
Sentrx, industry leader in providing outsourced drug safety solutions, comprehensive pharmacovigilance solutions and data management services, comments on new E.U. Regulations. - August 02, 2012 - Sentrx
"Vaccines Market Will Reach $33.8 Billion in 2012" Visiongain Report Predicts
A new report by visiongain predicts that the 2012 world market for vaccines to treat human beings will reach $33.8 billion. That revenue forecast appears in World Vaccines Market 2012-2022, published in July 2012. Visiongain is a business information provider based in London, UK. - July 27, 2012 - visiongain
"World Biomarkers Market Will Reach $15.29 Billion in 2012" New Visiongain Report Predicts
A new report by visiongain predicts that the global market for biomarkers will be worth $15.29 billion in 2012. Between 2011 and 2016, the world market will grow with a CAGR of 11.0%. Increased use of biomarkers in drug development will drive growth. Those findings appear in Biomarkers: Technological and Commercial Outlook 2012-2022, published in July 2012. - July 25, 2012 - visiongain
FyMed Demonstrates Superiority of FY101C Over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed, Inc. today announced results from comparative in-vivo studies of FY101C, its lead NSAID candidate, which demonstrated significant superiority to conventional NSAIDs in terms of efficacy and safety in the management of acute and chronic pain and inflammation. - July 25, 2012 - FyMed Inc
A New Marketing Tool for Pharmaceutical Sales Reps - DoctorDinners.com
DoctorDinners.com is comprehensive online resource for physicians and other medical providers interested in pharmaceutical industry sponsored informational gatherings, commonly known as “Drug Rep Dinners.” Pharmaceutical reps, physicians, and restaurants alike are sure to benefits from this convenient and resourceful site. - July 21, 2012 - DoctorDinners.com
"Global Medical Device Market Will Reach $397.1bn by 2016" According to New Visiongain Report
A new report by visiongain, a London-based business information provider, predicts that the global medical device market will be worth $397.1bn by 2016. The market generated $309.0bn in 2011, according to Medical Devices Industry and Market Prospects 2012-2022, published in July 2012. - July 14, 2012 - visiongain
pharmaCline's Diabecline Antibiotic Nominated for 2012 American Business Awards, Stevie Awards
The American Business Awards has named pharmaCline® as a finalist for the 2012 Stevie Award for New Product of the Year- Health & Pharmaceuticals. The Stevie Awards were created to honor and generate public recognition of the achievements and positive contributions of organizations and... - July 12, 2012 - pharmaCline
Achieving Quality and Compliance Excellence in Pharmaceuticals - New Book Released
This latest book released by Business Horizons represents the latest global quality standards that pharmaceutical manufacturers are striving for today, in order to achieve compliance in today's stringent norms by regulatory agencies. - July 09, 2012 - Business Horizons
Chinese Pharma Growth Expected to Slow Amid Reform Turbulences and Intensified Cost Containment
Although there are growing concerns about China’s economy and uncertainties about the country’s healthcare reforms, the Chinese pharmaceutical industry maintained healthy growth in 2011 and the first half of 2012 as well as a generally positive outlook, according to China Pharmaceutical... - July 06, 2012 - WiCON International Group LLC
Artcraft Health Education Wins 3 Healthcare Advertising Awards
Artcraft Health Education, a leader in health education solutions, wins 3 healthcare advertising awards for patient education materials. - July 05, 2012 - Artcraft Health Education
Artcraft Health Education Wins 13 Communicator Awards
Artcraft Health Education, a leader in health education solutions, wins 13 awards for patient education materials. - July 03, 2012 - Artcraft Health Education
"Global Market for in Vitro Diagnostics Will Reach $126.9bn by 2022" According to Visiongain Report
A new report by visiongain, a London-based business information provider, predicts that the global market for in vitro diagnostics will be worth $126.9bn by 2022. The market generated sales of $47.6bn in 2011 and includes all devices, reagents, instruments or systems used to perform diagnoses from biological assays, or more generally, in a controlled environment outside the living organism. The IVD sector is currently the largest sector in the global medical devices market. - June 30, 2012 - visiongain
AdvantaPure(R) Now Offers Extractables Test Results for Its Silicone & TPE Tubing Products; Helps End Users Select Suppliers & Tubing
High purity processing components are critical in pharmaceutical, biopharmaceutical, and other clean applications. AdvantaPure’s silicone and thermoplastic elastomer tubing has been extensively tested for extractables to prove the products’ suitability for high purity uses. Complimentary summary and comprehensive reports are available from the company upon request. - June 29, 2012 - NewAge Industries, Inc.
Medimix International Joins The TRUST ALLIANCE – Professional Organization to Enforce Quality Standards in Online Healthcare Data Collection
Medimix International announced that their company has joined The Trust Alliance-- an organization whose mission is to advance and promote best practices in healthcare data collection and to foster trust in online physician research. Although its members remain competitors, they come together because they are all passionate about providing quality data to their clients. - June 27, 2012 - Medimix International
ALPCO & Argutus Medical Collaboration
Kidney & Liver Toxicity Gold Standard Rat Alpha GST ELISA Available Once Again - June 26, 2012 - ALPCO
"Pfizer Will be the Leading Antibacterial Drug Manufacturer in 2012, with Revenue of $3.23bn" Says Visiongain Report
A new report by visiongain predicts that Pfizer will retain its position as the global leader in the antibacterial drugs market in 2012. - June 23, 2012 - visiongain
Artcraft Health Education Wins 12 Hermes Creative Awards
Artcraft Health Education, a leader in health education solutions, wins 12 awards for patient education materials. - June 23, 2012 - Artcraft Health Education
"Pharma Wholesale and Distribution Market Will Reach $747bn in 2014" Visiongain Report Predicts
A new report by visiongain predicts that the world market for pharmaceutical wholesale and distribution (W&D) activities will reach $747 billion for 2014. That revenue forecast appears in Pharma Wholesale and Distribution Market: World Outlook 2012-2022, published in June 2012. Visiongain is a business information provider based in London, UK. - June 21, 2012 - visiongain
The Hamner Institutes for Health Sciences Announces Formation of DILI-sim Initiative
Nonprofit Institute is Spearheading Multi-stakeholder Partnership to Use Computer Model to Make Drugs Safer - June 21, 2012 - The Hamner Institutes for Health Sciences
Global Digital Forensics Provides Expert eDiscovery Guidance as the Courts Establish New Guidelines for Legal Counsel
Electronic discovery firm Global Digital Forensics handles the complex process of securing Electronically Stored Information (ESI) and places its clients in an advantageous position as judges demand better eDiscovery practices. - June 20, 2012 - Global Digital Forensics
Inventys Research Butibori (Nagpur) Plant, Achieves ISO 9001:2008, ISO 14000:2004, and ISO 18000:OSHAS Certification
Inventys Research Company has achieved ISO 9001:2008, 14001:2004 and 18000:OSHAS Management System accreditation. The ISO 9001:2008 certification of compliance recognizes that the policies, practices, and procedures of Inventys ensure consistent quality in the products and services Inventys... - June 13, 2012 - Inventys Research Company Pvt Ltd.
"OTC Pharma Market Will Reach $80.7 Billion in 2014" Visiongain Report Predicts
A new report by visiongain predicts that the world market for over-the-counter (OTC) medicines will reach $80.7 billion for 2014. That revenue forecast appears in World OTC Pharmaceutical Market 2012-2022, published in June 2012. Visiongain is a business information provider based in London, UK. - June 13, 2012 - visiongain
Dr. Scott Siler to Discuss DILIsym Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012. - June 12, 2012 - Rosa & Co LLC